Strategic Financial Concepts LLC Makes New $261,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Strategic Financial Concepts LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 528 shares of the healthcare conglomerate’s stock, valued at approximately $261,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Bray Capital Advisors increased its stake in shares of UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in UnitedHealth Group by 0.5% during the 3rd quarter. Asset Management One Co. Ltd. now owns 479,578 shares of the healthcare conglomerate’s stock worth $241,798,000 after buying an additional 2,245 shares during the last quarter. Warren Street Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 10.3% during the third quarter. Warren Street Wealth Advisors LLC now owns 783 shares of the healthcare conglomerate’s stock valued at $395,000 after buying an additional 73 shares during the last quarter. Blue Fin Capital Inc. lifted its holdings in UnitedHealth Group by 1.6% in the third quarter. Blue Fin Capital Inc. now owns 14,861 shares of the healthcare conglomerate’s stock worth $7,493,000 after purchasing an additional 234 shares during the period. Finally, WestEnd Advisors LLC increased its position in shares of UnitedHealth Group by 9.6% during the 3rd quarter. WestEnd Advisors LLC now owns 72,726 shares of the healthcare conglomerate’s stock valued at $36,668,000 after purchasing an additional 6,360 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.1 %

UNH traded down $5.33 during trading on Tuesday, hitting $483.70. The company’s stock had a trading volume of 3,366,904 shares, compared to its average volume of 4,466,545. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock’s fifty day moving average price is $484.44 and its 200-day moving average price is $513.42. The firm has a market capitalization of $445.04 billion, a P/E ratio of 29.57, a PEG ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is presently 45.97%.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent analyst reports. Piper Sandler boosted their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Morgan Stanley reduced their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Finally, Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.